HEALTHCARE INSIGHTS
HEALTHCARE INSIGHTS
  • Home
  • #Global Trends
  • #Vietnam
  • #M&A
  • #Regulations
  • #Knowledge
    • #Corporate Wellness
    • #Human Resources
    • #Capability Development
    HEALTHCARE INSIGHTS
    HEALTHCARE INSIGHTS

    Tag: #Global Trends

    The European Commission approves AbbVie’s Skyrizi for pediatric patients with moderate to severe plaque psoriasis

    23/06/2026 Published by Pharma Biz

    Biopharmaceutical leader AbbVie has announced that the European Commission (EC) has formally granted marketing authorization expanding the indication for its... Read more

    Category: Uncategorized
    Tags: #Global Trends

    US FDA declines to approve Achieve Life Sciences’ smoking-cessation drug over third-party manufacturing deficits

    23/06/2026 Published by Pharma Biz

    The U.S. Food and Drug Administration (FDA) has declined to approve Achieve Life Sciences' experimental drug engineered to treat adult... Read more

    Category: Uncategorized
    Tags: #Global Trends

    Pfizer’s experimental antibody-drug conjugate misses primary endpoint in late-stage lung cancer trial

    23/06/2026 Published by Pharma Biz

    Global pharmaceutical giant Pfizer Inc. announced that a key experimental oncology drug acquired through its high-premium $43,000 million buyout of... Read more

    Category: Uncategorized
    Tags: #Global Trends

    Shopify set to ban all vape products from its e-commerce platform under intense U.S. regulatory pressure

    23/06/2026 Published by Pharma Biz

    Ottawa-based e-commerce infrastructure giant Shopify Inc. is poised to ban all vaporizers and e-cigarettes (vapes) from its web hosting and... Read more

    Category: Uncategorized
    Tags: #Global Trends

    Global oncological milestone: China approves world’s first solid tumor-targeted CAR-T cell therapy

    23/06/2026 Published by Pharma Biz

    China’s National Medical Products Administration (NMPA) has executed a series of historic regulatory clearances, spearheaded by the landmark global approval... Read more

    Category: Uncategorized
    Tags: #Global Trends

    SK pharmteco partners with OTXL to accelerate clinical timelines for rare disease therapeutics

    22/06/2026 Published by Pharma Biz

    Global CDMO giant SK pharmteco has finalized a definitive collaborative agreement with the Orphan Therapeutics Accelerator (OTXL)—a non-profit biotechnology organization... Read more

    Category: Uncategorized
    Tags: #Global Trends

    Neurizon and Elanco ink long-term supply agreement for human-grade Monepantel to anchor ALS clinical pipeline

    22/06/2026 Published by Pharma Biz

    Biopharmaceutical innovator Neurizon Therapeutics has formalized a strategic, long-term supply agreement with Elanco Animal Health to secure comprehensive access to... Read more

    Category: Uncategorized
    Tags: #Global Trends

    Lupin launches generic Azilsartan Medoxomil tablets in the US with 180-day market exclusivity

    19/06/2026 Published by Pharma Biz

    Global pharmaceutical enterprise Lupin Limited has officially announced the commercial launch of Azilsartan Medoxomil Tablets in 40 mg and 80... Read more

    Category: Uncategorized
    Tags: #Global Trends

    FDA expands indication for Merck’s Capvaxive to include high-risk pediatric populations aged 2 to 17

    19/06/2026 Published by Pharma Biz

    The U.S. Food and Drug Administration (FDA) has granted an expanded indication for Merck & Co.’s 21-valent pneumococcal conjugate vaccine,... Read more

    Category: Uncategorized
    Tags: #Global Trends

    Posts pagination

    Page 1 Page 2 … Page 72 Next page

    Facebook

    Map

    Workday: Monday to Friday
    Working hours: 8am to 5pm
    Address: 8th floor, Hyco 4 building, 205A Nguyen Xi Street, Binh Thanh Ward, HCMC

    Please enable JavaScript in your browser to complete this form.
    Get Your Weekly Market Insights Stay informed on Vietnam's market & Healthcare Alliance updates
    Loading

    Online Members

    Recent Comments

    • GauTruc on New Biotech Startup Secures $125 Million to Advance Pain Medication
    HEALTHCARE INSIGHTS
    All rights reserved